Concurrent celecoxib versus placebo in patients with stage II-III non-small cell lung cancer: A randomised phase II trial

被引：12

作者：

De Ruysscher, Dirk

Bussink, Johan

Rodrigus, Patrick

Kessels, Alfons

Dirx, Miranda

Houben, Ruud

Wanders, Rinus

机构：

[1] Univ Hosp Maastricht, Dept Radiat Oncol, GROW, NL-6229 ET Maastricht, Netherlands

[2] MAASTRO Clin, Maastricht, Netherlands

[3] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands

[4] Bernard Verbeeten Inst, Tilburg, Netherlands

[5] Univ Hosp Maastricht, Dept Hlth Technol Assessment, Maastricht, Netherlands

[6] Comprehens Canc Ctr Limburg, Maastricht, Netherlands

来源：

RADIOTHERAPY AND ONCOLOGY | 2007年 / 84卷 / 01期

关键词：

COX-2; celecoxib; randomised; phase II; NSCLC; radiotherapy;

D O I：

10.1016/j.radonc.2007.05.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In several pre-clinical models, cyclooxygenase (COX) inhibitors increase radio-sensitivity of tumours, whilst not affecting normal tissues. A randomised phase II trial comparing concurrent radiotherapy with either celecoxib or placebo in patients with stage II-III non-small cell lung cancer was therefore initiated. Because of poor recruitment, the study was stopped after the enrollment of 41 patients, instead of the foreseen 102. None of the endpoints differed significantly between both groups. However, due to the limited number of patients, no definitive conclusions can be drawn. (c) 2007 Elsevier Ireland Ltd. All rights reserved.

引用

收藏

页码：23 / 25

页数：3

相关论文

共 50 条

[21] Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410 [J].

Curran, Walter J., Jr. ;

Paulus, Rebecca ;

Langer, Corey J. ;

Komaki, Ritsuko ;

Lee, Jin S. ;

Hauser, Stephen ;

Movsas, Benjamin ;

Wasserman, Todd ;

Rosenthal, Seth A. ;

Gore, Elizabeth ;

Machtay, Mitchell ;

Sause, William ;

Cox, James D. .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (19) :1452-1460

[22] INITIAL TOXICITY AND COMPLIANCE EVALUATION FOR CONSOLIDATION PEMETREXED FOLLOWING CONCURRENT CHEMORADIOTHERAPY (CCTRT) IN STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II TRIAL [J].

Helbrow, Jonathan ;

Faivre-Finn, Corinne ;

Bayman, Neil ;

Burt, Paul A. ;

Chittalia, Abbas ;

Harris, Maggie A. ;

Lander, Helen ;

Lee, Lip W. ;

Pemberton, Laura ;

Sheikh, Hamid ;

Taylor, Paul ;

Ashcroft, Linda ;

Blackhall, Fiona .

JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S1196-S1196

[23] A phase III randomized trial of postoperative adjuvant therapy in Stage II or IIIA completely resected non-small cell lung cancer [J].

Yoon, S ;

Choi, E ;

Kim, S ;

Suh, C ;

Lee, J ;

Shim, T ;

Kim, W ;

Kim, D ;

Park, S ;

Park, C .

LUNG CANCER, 2005, 49 :S288-S288

[24] Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC) [J].

Hainsworth, John D. ;

Waterhouse, David M. ;

Shih, Kent C. ;

Boccia, Ralph, V ;

Priego, Victor M. ;

McCleod, Michael J. ;

Kudrik, Fred J. ;

Mitchell, Reed Brian ;

Burris, Howard A., III ;

Greco, F. Anthony ;

Spigel, David R. .

LUNG CANCER, 2018, 118 :6-12

[25] A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer [J].

Cakir, S ;

Egehan, I .

LUNG CANCER, 2004, 43 (03) :309-316

[26] PHASE II TRIAL OF IMATINIB MESYLATE AND DOCETAXEL IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER [J].

Papadimitrakopoulou, Vassiliki ;

Liu, Suyu ;

Fujimoto, Junya ;

Wistuba, Ignacio ;

Lee, J. J. ;

Marom, Edith M. ;

Charnsangavej, Chusilp ;

Fossella, Frank V. ;

Tran, Hai T. ;

Blumenschein, George ;

Kies, Merrill ;

Hong, Waun K. ;

Stewart, David J. ;

Tsao, Anne .

JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S1235-S1235

[27] Phase II trial of carboplatin, paclitaxel plus vinorelbine in non-small cell lung cancer patients [J].

Schmittel, A ;

Siehl, JM ;

Schulze, M ;

Schulze, K ;

Thiel, E ;

Keilholz, U .

ANTICANCER RESEARCH, 2005, 25 (2B) :1333-1336

[28] The effect of PD-L1 status on survival outcomes in patients with stage II-III non-small cell lung cancer treated with chemotherapy [J].

Karaca, Mustafa ;

Tural, Deniz ;

Akar, Emre ;

Unal, Damla ;

Bayraktaoglu, Mesut ;

Akyurek, Nalan ;

Ozet, Ahmet .

JOURNAL OF BUON, 2020, 25 (01) :268-273

[29] Clinical observation of docetaxel or gemcitabine combined with cisplatin in the chemotherapy after surgery for stage II-III non-small cell lung cancer [J].

Chen, Qiu-Qiang ;

Ji, Xue-Xian ;

Zhou, Xiao ;

Shi, Qi-Lin ;

Yu, Huan-Ming ;

Fu, Heng-Qin ;

Ji, Guo-Ping .

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2015, 19 (04) :323-326

[30] Treatment and toxic effects of prophylactic cranial irradiation in stage II-III non-small cell lung cancer: A meta-analysis [J].

Li, Meng ;

Wang, Taifang ;

Wen, Ping ;

Wang, Xiang ;

Wu, Chunli .

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (02) :E18-E26

← 1 2 3 4 5 →